Azafaros' Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled
Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolledTopline data from the study, exp...
United Kingdom United States Porto Alegre Roberto Giugliani Leiden University European Medicines Agency
Source: businessinsider.com